KEMRI receives Sh77.2m grant from Gov’t agency for stem cell research,
KEMRI receives Sh77.2m grant from Gov’t agency for stem cell research
The National Research Fund (NRF) has given the Kenya Medical Research Institute (KEMRI) Sh77.2 million to conduct stem cell research in an effort to find treatments for individuals suffering from various illnesses.
The funding will be used by the institution’s research scientists to create new technologies for the diagnosis, treatment, and prevention of non-communicable diseases, which account for 27% of all fatalities each year.
At the inauguration of the Centre of Excellence in Stem Research at the KEMRI headquarters in Nairobi, National Research Fund Chairman Prof. Ratemo Michieka stated that the project would allow researchers to employ stem cells to develop solutions that could be applied both domestically and abroad.
Michieka urged the scientists to choose a material that they could manufacture and use to aid the country in research and development to generate jobs, noting that identifying their strongest research areas would help their theories gain recognition and be evaluated internationally.
The facility for stem cell research, according to remarks made by Dr. Abdullahi Ibrahim, Chairman of the KEMRI Board of Directors, would address the enormous problem of non-communicable diseases in the nation, which account for more than 50% of in-patient hospital admissions.The Chairman of the National Research Fund, Professor Ratemo Michieka, stated that the initiative will enable scientists to use the stem cells to come up with solutions that can be employed both locally and worldwide. The commissioning of the Centre of Excellence in Stem Research took place at the headquarters of KEMRI in Nairobi.
Michieka posed a challenge to the researchers, requesting that they choose a substance that they are capable of manufacturing and contributing to the nation’s research and development efforts in order to provide employment opportunities. She also mentioned that the scientists should identify particular facets of their work that are particularly strong so that their hypothesis can be evaluated and ranked on a global scale.
Dr. Abdullahi Ibrahim, Chairman of the KEMRI Board of Directors, stated in his remarks that the stem cell research facility will address the enormous problem of non-communicable diseases in the country, which are responsible for more than fifty percent of all in-patient hospital admissions.